Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 13-Sep-2018
No. of pages: 118

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Scope of the Report:

This report studies the Companion Diagnostic Tests in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Diagnostic Tests in Oncology market by product type and applications/end industries.

The global Companion Diagnostic Tests in Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Diagnostic Tests in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

-Abbott

-Roche

-Genomic Health

-QIAGEN

-Agilent

-Agendia

-BioMerieux

-Illumina

-Siemens Healthcare

-Thermo Fisher

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Protein Detection

-DNA Detection

Market Segment by Applications, can be divided into

-Pharmaceutical & Biotechnology Companies

-Medical Device Companies

-Research Institutes

Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Companion Diagnostic Tests in Oncology Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology
1.2 Classification of Companion Diagnostic Tests in Oncology by Types
1.2.1 Global Companion Diagnostic Tests in Oncology Revenue Comparison by Types (2017-2023)
1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017
1.2.3 Protein Detection
1.2.4 DNA Detection
1.3 Global Companion Diagnostic Tests in Oncology Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Global Companion Diagnostic Tests in Oncology Market by Regions
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.5 Global Market Size of Companion Diagnostic Tests in Oncology (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Companion Diagnostic Tests in Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Companion Diagnostic Tests in Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genomic Health
2.3.1 Business Overview
2.3.2 Companion Diagnostic Tests in Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.4 QIAGEN
2.4.1 Business Overview
2.4.2 Companion Diagnostic Tests in Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Agilent
2.5.1 Business Overview
2.5.2 Companion Diagnostic Tests in Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Agendia
2.6.1 Business Overview
2.6.2 Companion Diagnostic Tests in Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.7 BioMerieux
2.7.1 Business Overview
2.7.2 Companion Diagnostic Tests in Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.8 Illumina
2.8.1 Business Overview
2.8.2 Companion Diagnostic Tests in Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens Healthcare
2.9.1 Business Overview
2.9.2 Companion Diagnostic Tests in Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Thermo Fisher
2.10.1 Business Overview
2.10.2 Companion Diagnostic Tests in Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Companion Diagnostic Tests in Oncology Market Competition, by Players
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share
3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share
3.3 Market Competition Trend
4 Global Companion Diagnostic Tests in Oncology Market Size by Regions
4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5 North America Companion Diagnostic Tests in Oncology Revenue by Countries
5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries
6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8 South America Companion Diagnostic Tests in Oncology Revenue by Countries
8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8.4 Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Companion Diagnostic Tests in Oncology by Countries
9.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.6 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
10 Global Companion Diagnostic Tests in Oncology Market Segment by Type
10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2013-2018)
10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2018-2023)
10.3 Protein Detection Revenue Growth Rate (2013-2023)
10.4 DNA Detection Revenue Growth Rate (2013-2023)
11 Global Companion Diagnostic Tests in Oncology Market Segment by Application
11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2013-2018)
11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2018-2023)
11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)
11.4 Medical Device Companies Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)
12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)
12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)
12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2018-2023)
12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Companion Diagnostic Tests in Oncology Picture
Table Product Specifications of Companion Diagnostic Tests in Oncology
Table Global Companion Diagnostic Tests in Oncology and Revenue (Million USD) Market Split by Product Type
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017
Figure Protein Detection Picture
Figure DNA Detection Picture
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Application (2013-2023)
Figure Companion Diagnostic Tests in Oncology Revenue Market Share by Applications in 2017
Figure Pharmaceutical & Biotechnology Companies Picture
Figure Medical Device Companies Picture
Figure Research Institutes Picture
Table Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Companion Diagnostic Tests in Oncology Type and Applications
Table Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Companion Diagnostic Tests in Oncology Type and Applications
Table Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Companion Diagnostic Tests in Oncology Type and Applications
Table Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Companion Diagnostic Tests in Oncology Type and Applications
Table QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Companion Diagnostic Tests in Oncology Type and Applications
Table Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Agendia Basic Information, Manufacturing Base and Competitors
Table Agendia Companion Diagnostic Tests in Oncology Type and Applications
Table Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Companion Diagnostic Tests in Oncology Type and Applications
Table BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Companion Diagnostic Tests in Oncology Type and Applications
Table Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Companion Diagnostic Tests in Oncology Type and Applications
Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Companion Diagnostic Tests in Oncology Type and Applications
Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2016
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2017
Figure Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017
Figure Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2017
Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
Table North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2017
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2018-2023)
Figure Global Protein Detection Revenue Growth Rate (2013-2018)
Figure Global DNA Detection Revenue Growth Rate (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2017
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2018-2023)
Figure Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2013-2018)
Figure Global Medical Device Companies Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
  • Global Human Placental Protein Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 116
    A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mothers blood supply. In addition, it aids in fighting against internal infection and produces hormones to support pregnancy. This placenta is further hydrolyzed and is used for a variety of applications as it has lactogenic, luteotropic, and growth-promoting action, and prevents maternal insulin action during pregnancy. ......
  • Global Hybrid Assistive Limb Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Hybrid assistive limb is a powered exoskeleton designed to support and expand the physical abilities of users who are physical disabled. In addition, this device can be used by elderly population for their daily tasks as well as it can also be utilized by workers in critical conditions such as disaster rescue or construction. Scope of the Report: This report focuses on the Hybrid Assistive Limb in global market, especially in North America, Europe and Asia-Pacific, ......
  • Global Hydroxytryptamine Receptor Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Hydroxytryptamine receptors are a group of G-protein coupled receptors and ligand gated ion channels, which are found in the peripheral and central nervous system. These receptors influence various biological and neurological processes such as aggression, anxiety, learning, mood, nausea, sleep, and cognition. Scope of the Report: This report studies the Hydroxytryptamine Receptor market status and outlook of Global and major regions, from angles of players, countrie......
  • Global Deaf Aid Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 4900 Onwards        Pages: 114
    This report studies the global market size of Deaf Aid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Deaf Aid in these regions. This research report categorizes the global Deaf Aid market by top players/brands, region, type and end user. This report also studies the global Deaf Aid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and chall......
  • Global Hydroxyzine Imine Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 120
    Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin. Scope of the Report:......
  • Global Immune Check Point Inhibitors Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack the cancer cells present inside the body, as well as avoids relapse of cancer cells. In case any relapse occurs in the body, it can easily be recognized and eliminated by the use of immune memory cells, leaving a healthy tissue. Scope of the Report: This report studies the Immune Check Point Inhibitors market status an......
  • Global Implantable Heart Pacemaker Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 136
    An implantable heart pacemaker is a medical device, which is implanted in the body of a patient. Implantable heart pacemaker delivers electrical impulses to the heart muscles to regulate heartbeat. Scope of the Report: This report focuses on the Implantable Heart Pacemaker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicat......
  • Global Implantable Insulin Pump Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 116
    Implantable insulin pump aids in delivering insulin into the peritoneal cavity and remains inside the body all the time. In addition, the insulin pump implanted in the peritoneal cavity helps in efficient absorption of insulin. The advent of implantable insulin pumps is anticipated to revolutionize the treatment of Type 1 diabetes and will also help find a constructive solution for truly effective artificial pancreas. Scope of the Report: This report focuses on the ......
  • 2018-2023 Global Auto-Injectors Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 158
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Auto-Injectors market for 2018-2023. Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug load......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs